According to HTG Molecular Diagnostics 's latest financial reports the company's current EPS (TTM) is -$23.41. In 2017 the company made an earnings per share (EPS) of -$349.20 an increase over its 2016 EPS that were of -$662.40.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$23.41 | |
2017 | -$349.20 | -47.28% |
2016 | -$662.40 | -79.9% |
2015 | -$3,296 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Lexicon Pharmaceuticals
LXRX | -$0.68 | -97.10% | ๐บ๐ธ USA |
Affimed
AFMD | -$0.79 | -96.62% | ๐ฉ๐ช Germany |
Calithera Biosciences
CALA | -$5.43 | -76.80% | ๐บ๐ธ USA |